Article

Alcon to expand manufacturing facility in West Virginia

Alcon Inc. broke ground on an expansion of its medical device manufacturing facility in Huntington, WV, Sept. 19.

Huntington, WV—Alcon Inc. broke ground on an expansion of its medical device manufacturing facility in Huntington, WV, Sept. 19.

To accommodate the expansion, the company purchased 21 acres in Cabell County with an option to purchase an additional 8 acres in the future. Alcon expects to spend more than $25 million during the first phase of development on the new, 74,000-square-foot building, which representatives said should be fully functional by 2011 and provide more than 350 jobs during the next 10 to 15 years. The current facility produces millions of IOLs and surgical delivery systems annually, according to the company.

“Alcon is a world leader in this field, and this expansion will keep them at the forefront of IOL technology and manufacturing,” said West Virginia Gov. Joe Manchin III at the groundbreaking ceremony. “We’re delighted our strong workforce and business climate have played a part in their growth, and the entire region will benefit from even more good jobs that Alcon brings with this announcement.”

Cary Rayment, Alcon’s chairman, president, and chief executive officer, told attendees, “We are very excited about our expansion and what it will mean for our customers, employees, and the community. With this additional capacity and growth in our skilled workforce, we will be able to meet the growing global demand for advanced cataract surgical products.”

In conjunction with the groundbreaking ceremony for the new facility, Alcon is celebrating its 30th year of IOL manufacturing in the state of West Virginia.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.